COMPANIES LOBBY TO SECURE PATENTS IN ANTARCTICA

AUTHOR: redOrbit staff & wire reports
PUBLICATION: redOrbit
DATE: 6 February 2009
URL:
http://www.redorbit.com/news/science/1635462/companies_lobby_to_secure_p...
________________________________________________________

RedOrbit - 6 February 2009

COMPANIES LOBBY TO SECURE PATENTS IN ANTARCTICA

Companies developing new products through biological discovery or "bioprospecting" are trying to file patents on Antarctic organisms or molecules for items ranging from cosmetics to medicines, putting new strains on the treaty demanding all scientific findings on Antarctica be freely shared.

Jose Retamales, head of the Chilean Antarctic Institute, told Reuters that biology is dealing with a tricky situation due to the lack of clear rules for prospecting for animals and plants in Antarctica.

An annual meeting commemorating "50 years of peace and science" will
include a debate over issues involving the 1959 Antarctic Treaty,
including bioprospecting.

Johannes Huber, head of the Antarctic Treaty Secretariat in Buenos
Aires, said the panel needed to find out if it is a problem and if so,
define that problem.

"Governments have not found a consensus," he added.

Retamales said the treaty setting the continent aside for peace and
science was originally intended to defuse bigger conflicts over
territorial claims during the Cold War.

The treaty prohibits mining but permits other commercial uses of
Antarctica. Bioprospecting is allowed, unless it has military goals.

The pursuit of patents is often hard to square with goals of openness
and shared science laid out in the 47-nation treaty, according to
Retamales and other experts.

The rules of the treaty state that scientific observations and results
from Antarctica shall be exchanged and made freely available and that
all plans for scientific programs should be exchanged in advance to
ensure efficiency and economy.

Products derived from Antarctica include dietary supplements,
anti-freeze proteins, anti-cancer drugs, enzymes and cosmetic creams.
Advances in genetic technologies make Antarctic "bioprospecting" easier.

Yves Frenot, deputy head of the French Polar Institute, said using
genetic resources means very often that you are having an economic
activity for a company. "That is difficult to reconcile with the
Antarctic Treaty."

Numerous companies, including consumer products groups Procter & Gamble
and Unilever, French cosmetics group Clarins and Danish drugmaker Novo
Nordisk are in a UNU database of almost 200 "bioprospecting" bodies.

Unilever has a patent based on an anti-freeze protein in a bacteria
found in an Antarctic lake that may help keep ice cream smooth.

?There are similar trends of more research into organisms found in the
high seas and on the deep seabed, despite uncertainties about rights
outside national waters,? said Sam Johnston, a senior research fellow at
the U.N. University's (UNU) Institute of Advanced Studies.

In Antarctica, all territorial claims are on hold under the treaty.

"Our view is that we can't patent organisms themselves but we can have
patents on processes discovered in Antarctic organisms," said Pete
Convey, a biologist at the Rothera research station on the Antarctic
Peninsula.

The treaty should not block a cancer treatment, for instance, found in
an Antarctic creature or plant and patented after costly research by a
company, Frenot said.

"It would be a pity not to use such resources, but there are no rules.
We have to invent those rules," he said.

According to Johnson, there are worries, but no evidence, that corporate
involvement might make researchers delay publication of key scientific
findings until patent applications were filed.

He suggested taxing profits from Antarctic-based products to put money
back into Antarctic science, with special help for poor countries. He
said the U.S. and Japan seemed most reluctant to impose rules that would
limit corporate access.

However, a lot of Antarctic patents go beyond animals or plants.

Norway's Aker Biomarine, which produces a dietary supplement made from
krill, has patents covering technology for processing the shrimp-like
crustaceans that can quickly rot.

Aker Biomarine spokesman Geir Arne Drangeid said the patents are not
really relevant to scientific research under the Antarctic Treaty.

________________________________________________________

GOING FURTHER (compiled by GRAIN)

BIO-IPR has been tracking this issue for several years. See
http://www.google.com/search?q=site:www.grain.org/bio-ipr+antarctica for
selected materials and references.